Omar Walid, Elsayed Marwa
Critical Care Department, Cairo University Hospitals, Cairo, Egypt.
Open Access Maced J Med Sci. 2019 Dec 10;7(23):4048-4052. doi: 10.3889/oamjms.2019.633. eCollection 2019 Dec 15.
Huge number of pro-inflammatory and anti-inflammatory markers is produced during the process of sepsis. Its mortality prediction value needs to be determined.
To assess the prognostic value of Albumin creatinine ratio (ACR) in septic patients and its ability to predict mortality in comparison with Acute physiology and chronic health evaluation II score (APACHE II).
Seventy-five Septic patients were included within 24 hours of sepsis diagnosis and were admitted to the intensive care unit (ICU). ACR values were obtained within 6 hours of ICU admission for all patients. Prognostic scoring systems [APACHE II and Sequential organ failure assessment (SOFA) scores] were calculated.
Twenty percent of enrolled patients died within 28 days of hospital admission. ACR was significantly higher in non-survivor in comparison to survivors (55.1 ± 20.5 versus 30.2 ± 35.7, p = 0.006). ACR ≥ 40 (mg/gm creatinine) was the cut-off point for predicting mortality with a sensitivity of 90.7% and specificity of 71.8% with total accuracy of 66% and AUC 0.75 (CI 0.62-0.88). Mean APACHE II score was significantly higher in non-survivors than survivor groups (21.4 versus 10.8, p < 0.001). ACR was positively correlated with highest SOFA score (r = 0.3, P < 0.05).
ACR is a simple prognostic marker in septic patient and could be used as a mortality predictor, particularly in early (within 6 hours) septic patients.
脓毒症过程中会产生大量促炎和抗炎标志物。其对死亡率的预测价值有待确定。
评估白蛋白肌酐比值(ACR)在脓毒症患者中的预后价值,以及与急性生理与慢性健康状况评分系统II(APACHE II)相比预测死亡率的能力。
75例脓毒症患者在诊断后24小时内纳入研究,并入住重症监护病房(ICU)。所有患者在入住ICU后6小时内获取ACR值。计算预后评分系统[APACHE II和序贯器官衰竭评估(SOFA)评分]。
20%的入选患者在入院28天内死亡。与存活者相比,非存活者的ACR显著更高(55.1±20.5对30.2±35.7,p = 0.006)。ACR≥40(mg/gm肌酐)是预测死亡率的切点,敏感性为90.7%,特异性为71.8%,总准确率为66%,曲线下面积为0.75(CI 0.62 - 0.88)。非存活者的平均APACHE II评分显著高于存活者组(21.4对10.8,p < 0.001)。ACR与最高SOFA评分呈正相关(r = 0.3,P < 0.05)。
ACR是脓毒症患者的一个简单预后标志物,可作为死亡率预测指标,特别是在早期(6小时内)脓毒症患者中。